P. Caporaso

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

T. Di Pucchio, P. Marchetti, E. Bonmassar, 2006, Cancer research.

Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.

E. Bonmassar, A. Aquino, V. Formica, 2010, Anticancer research.

O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro.

E. Bonmassar, A. Venditti, F. Buccisano, 2006, Pharmacological research.

A single cycle of treatment with temozolomide, alone or combined with O(6)-benzylguanine, induces strong chemoresistance in melanoma cell clones in vitro: role of O(6)-methylguanine-DNA methyltransferase and the mismatch repair system.

J. Jiricny, P. Lacal, E. Bonmassar, 2006, International journal of oncology.

Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.

Stefano Volinia, Diego Arcelli, C. Croce, 2009, International journal of oncology.

Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia.

E. Bonmassar, A. Venditti, F. Buccisano, 2007, DNA repair.

Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.

E. Bonmassar, S. Caporali, E. Pagani, 2007, International journal of oncology.

MicroRNA‐155 targets the SKI gene in human melanoma cell lines

S. Bondanza, F. Martelli, E. Bonmassar, 2011, Pigment cell & melanoma research.